Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention

This publication has 26 references indexed in Scilit:

• Universal Definition of Myocardial Infarction
  Journal of the American College of Cardiology, 2007
• Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention
  Journal of the American College of Cardiology, 2007
• Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention: Results From the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) Substudy
  Journal of the American College of Cardiology, 2006
• Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
  Circulation, 2006
• Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel
  Methods and Findings in Experimental and Clinical Pharmacology, 2006
• Platelet Reactivity in Patients and Recurrent Events Post-Stenting
  Journal of the American College of Cardiology, 2005
• Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention
  Circulation, 2005
• Platelet Function Testing in Cardiovascular Diseases
  Circulation, 2004
• Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention
  Circulation, 2004
• Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
  Journal of the American College of Cardiology, 1988